Literature DB >> 2493179

Inhibition of cytokine production by cyclosporine A and G.

R M McKenna1, K Szturm, J R Jeffery, D N Rush.   

Abstract

Cyclosporine G (CsG) is an analogue of CsA that may not have the nephrotoxicity of CsA. Not much is known about the relative immunosuppressive activity of CsG compared with CsA in humans. For this reason we compared the effects of CsA and CsG on in vitro interferon gamma production by mitogen and alloantigen-stimulated peripheral blood mononuclear cells from normal individuals. We also investigated the effects of CsA and CsG on the production of lymphotoxin (LT) and tumor necrosis factor (TNF) activity, as these cytokines have been implicated in transplant rejection. Both CsA and CsG showed very similar dose-dependent inhibition of IFN-G and LT/TNF activity (IC50 CsA for IFN-G = 8.0 ng/ml, for LT/TNF = 9.5 ng/ml; IC50 CsG for IFN-G = 13.0 ng/ml, for LT/TNF = 13.0 ng/ml). Maximum suppression was seen if the drugs were added at culture initiation and suppression was reduced if the drugs were added 24 hr later. Both CsA and CsG showed significant dose- and time-dependent inhibition of IFN-G production in 2 degrees MLC. LT/TNF activity was suppressed by CsA and CsG in 2 degrees MLC, which was also dose- and time-dependent. These results suggest that CsG has an immunosuppressive profile similar to that of CsA and may therefore be useful in clinical situations where CsA nephrotoxicity is a problem.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493179     DOI: 10.1097/00007890-198902000-00032

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  The effect of cyclosporin A administration on bone metabolism in the rat evaluated by biochemical markers.

Authors:  K Kawana; M Takahashi; K Kushida; H Hoshino; S Sakata; T Inoue
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

Review 2.  International consensus recommendations on cyclosporin use in rheumatoid arthritis.

Authors:  P Tugwell
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Current status of renal transplantation.

Authors:  M G Suranyi; B M Hall
Journal:  West J Med       Date:  1990-06

4.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A.

Authors:  G Tiegs; J Hentschel; A Wendel
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 5.  New immunosuppressive agents for pediatric transplantation.

Authors:  M Ferraresso; B D Kahan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.